Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without Teletherapy
Author:
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 82 (2) , 371-374
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ADENOCARCINOMA of the UTERUS2002
- National Cancer Data Base/Surveillance Epidemiology and End Results: Potential Insensitive-Measure BiasGynecologic Oncology, 2000
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trialThe Lancet, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancerInternational Journal of Gynecological Cancer, 1998
- Stage I corpus cancer: Is teletherapy necessary?American Journal of Obstetrics and Gynecology, 1997
- The Practice of Surgical Staging and Its Impact on Adjuvant Treatment Recommendations in Patients with Stage I Endometrial CarcinomaGynecologic Oncology, 1996
- Surgical Staging and High Dose Rate Brachytherapy for Endometrial Cancer: Limiting External Radiotherapy to Node-Positive TumorsObstetrics & Gynecology, 1996
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991